Max Robotics — Global Service Robot Directory + US Certification

About

Chase M. Heaton is a leading surgical oncologist whose research focuses on human papillomavirus (HPV)-associated oropharyngeal cancer, with a particular emphasis on refining treatment through transoral robotic surgery (TORS). His work has fundamentally advanced the understanding of nodal disease patterns in HPV-positive oropharynx squamous cell carcinoma (OPSCC), as demonstrated by his highly cited 2018 study characterizing neck lymph node metastases (29 citations). Heaton has made pivotal contributions to surgical decision-making, including quantifying the risk of pathologic extranodal extension and other adverse features after TORS (21 citations), helping surgeons better counsel patients on individualized treatment pathways. His research also addresses practical postoperative outcomes, such as the necessity of nasogastric tube feeding after TORS and long-term quality of life in patients treated with surgery alone—a prospective study published in 2023. Beyond oncology, Heaton has explored innovative applications of TORS, including excision of retropharyngeal intramuscular lipomas. With a growing body of work that directly impacts clinical practice and patient counseling, Heaton is recognized as a key figure in the evolution of minimally invasive surgical management for HPV-associated oropharyngeal cancer.